References
- 1. Kempen JH, Altaweel MM. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010;149:550–561
- 2. Caskun E, Celemler P, Kimyon G, Oner V, Kisacik B, rrbagci I, Mesut OA. Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results. Ocular Immunology and inflammation 2015: 23(6)
- 3. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular Pressure Elevation after Intravit-real Triamcinolone Acetonide Injection. Ophtalmology 2005;112,593-8.
- 4. Palmberg P. Risk factors for glaucoma progression: Where does intraocular pressure fit in? Arch Ophthalmol 2001;119:897-8.
- 5. Yamamoto Y, Komatsu T, Koura Y, Nishino K, Fukushima A, Ueno H. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection. Can J Ophthalmolo. 2008; 43(1):42-7 doi 10.3129/i07-186
- 6. Gilles MC, Simson JM, Billson FA, Luo W, Penfold P, Chua W, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophtalmol 2004;122:336-40
- 7. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW. Endophtalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophtalmol 2003;121:271-3.
- 8. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed non-infectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23(5):686-91
- 9. Negi, AK, Browning AC, Vernon AS, Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial. J. Cataract Refract Surg. 2006; 32 (3): 468-74
- 10. McGhee CN. Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol 1992; 76:681-684
- 11. Helm CJ, Holland GN. The effect of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
- 12. Yannuzzi, L.A. A perspective on the treatment of aphakic cystoid macular edema. Surv Ophthalmol. 1984; 28: 540–553
- 13. Tugal-Tutkun, I., Herbort, C.P., Khairallah, M., and Angiography Scoring for Uveitis Working Group (ASUWOG). Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol. 2010; 30: 539–552
- 14. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacitates Classification Sistem III. The Longitudinal Study of Cataract Study Group. Arch Ophtalmol 1993;111:831-6.
- 15. Lafranco Dafflon M, Tran VT, Guex/Crosier Y, Herbot CP. Posterior sub-Tenon’s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 1999;237(4):289-95
- 16. Jovanović S, Vukosavljević M, Jovanović M, Stanojević-Paović A. Oftalmološke manifestacije hronične sarkoidoze. Ser J Exp Clin Res 2008;9(1):27-30.
- 17. Zlatanović G, Jovanović S, Živković M, Zlatanović M, Srecković S, Radotić F. The efficacy of novel therapeutic modalities of isolated ocular vasculitis vs ocular vasculitis as a systemic disease. Med Glas Ljek komore Zenicko-Doboj kantona 2012;9(1):66-73
- 18. Pickrel A, Harris A, Ngo S, Amireskandari A, Stewart E, Siesky B. Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema Pharmaceutics 2012; 4(1), 230-42.
- 19. Dal Canto AJ, Downs-Kelly E, Pery JD. Ptosis and Orbital Fat Prolapse after Posterior Sub–Tenon’s Capsule Triamcinolone Injection. Ophthalmology 2006; 112(6) 1092-97
- 20. Ferrante P, Ramsey A, Bunce C, Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Experiment Ophthalmol. 2004;32(6):563-8